相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation
Larisa Broglie et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Jason R. Schwartz et al.
NATURE COMMUNICATIONS (2021)
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
Deepak Singhal et al.
LEUKEMIA (2021)
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study
Katie S. Gatwood et al.
BONE MARROW TRANSPLANTATION (2020)
Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT
Frederic Baron et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts
George B. McDonald et al.
ANNALS OF INTERNAL MEDICINE (2020)
Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan
Michiko Kida et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome
Mikko Myllymaki et al.
BLOOD (2020)
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome
Piyanuch Kongtim et al.
BONE MARROW TRANSPLANTATION (2019)
Induction, Bridging, or Straight Ahead: The Ongoing Dilemma of Allografting in Advanced Myelodysplastic Syndrome
Nicolaus Kröger
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
Christer Nilsson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation
Catherine J. Lee et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT
Gerbrig Berger et al.
BLOOD (2018)
High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group
Adam Gassas et al.
BONE MARROW TRANSPLANTATION (2018)
Nationwide survey of therapy-related leukemia in childhood in Japan
Toshihiko Imamura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study
Catherine A. Brown et al.
PEDIATRIC BLOOD & CANCER (2018)
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study
Salyka Sengsayadeth et al.
BLOOD ADVANCES (2018)
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
Bart L. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation
J. Finke et al.
BONE MARROW TRANSPLANTATION (2016)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong et al.
NATURE (2015)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia
Kjeld Schmiegelow et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Smita Bhatia
SEMINARS IN ONCOLOGY (2013)
Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Rachel Kobos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
Sabine Kayser et al.
BLOOD (2011)
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Mark R. Litzow et al.
BLOOD (2010)
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
Nicolaus Kroeger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia The MD Anderson Cancer Center Experience
Dolly G. Aguilera et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies
Stella M. Davies
PEDIATRIC BLOOD & CANCER (2007)
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group
Smita Bhatia et al.
BLOOD (2007)
Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome
Paul Woodard et al.
PEDIATRIC BLOOD & CANCER (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
分享论文
